1. Home
  2. NWPX vs ALT Comparison

NWPX vs ALT Comparison

Compare NWPX & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NWPX

Northwest Pipe Company

N/A

Current Price

$64.22

Market Cap

610.5M

Sector

Industrials

ML Signal

N/A

Logo Altimmune Inc.

ALT

Altimmune Inc.

HOLD

Current Price

$3.88

Market Cap

415.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWPX
ALT
Founded
1966
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
610.5M
415.3M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
NWPX
ALT
Price
$64.22
$3.88
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$62.50
$16.33
AVG Volume (30 Days)
63.8K
4.7M
Earning Date
10-29-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
24.50
N/A
EPS
3.66
N/A
Revenue
$519,991,000.00
$20,000.00
Revenue This Year
$8.18
N/A
Revenue Next Year
$1.02
N/A
P/E Ratio
$17.50
N/A
Revenue Growth
7.64
N/A
52 Week Low
$36.97
$2.90
52 Week High
$65.84
$8.05

Technical Indicators

Market Signals
Indicator
NWPX
ALT
Relative Strength Index (RSI) 69.99 34.70
Support Level $63.85 $3.83
Resistance Level $65.31 $5.37
Average True Range (ATR) 1.51 0.39
MACD 0.15 -0.20
Stochastic Oscillator 78.37 1.43

Price Performance

Historical Comparison
NWPX
ALT

About NWPX Northwest Pipe Company

NWPX Infrastructure Inc is a manufacturer of water-related infrastructure products. The Company is the manufacturer of engineered water transmission systems in North America and produces steel casing pipe, bar-wrapped concrete cylinder pipe, and pipeline system joints and fittings through its Engineered Steel Pressure Pipe segment. The Company provides solution-based products for a wide range of markets, including high-quality reinforced precast concrete products, lined precast sanitary sewer system components, water distribution and management equipment, including pump lift stations, wastewater pretreatment, and stormwater quality products through its Precast Infrastructure and Engineered Systems segment.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: